BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Data on Tepotinib for metastatic non–small cell lung cancer presented at ESMO Asia 2019

  Merck, a leading science and technology company, today announced the presentation of multiple abstracts on tepotinib* at the European Society for Medical Oncology (ESMO) Asia Congress 2019 in Singapore.

  November 25, 2019

   · 

  3 min read
• Drug Development

  ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of CancerFirst asparaginase-based therapy to demonstrate clinical efficacy and safety in solid tumors

  ERYTECH Pharma announced that the full results from its Phase 2b trial evaluating eryaspase in metastatic pancreatic cancer are now published online in the European Journal of Cancer.

  November 25, 2019

   · 

  8 min read
• BrainsWay‘s New Stimulator for Deep Transcranial Magnetic Stimulation Makes German Debut at the 2019 German Association for Psychiatry, Psychotherapy and Psychosomatics Congress

  BrainsWay Ltd. announced that it will be exhibiting its new state-of-the-art deep transcranial magnetic stimulation platform for the first time in Germany, at the 2019 German Association for Psychiatry, Psychotherapy and Psychosomatics Congress scheduled to take place in Berlin from November 27-30, 2019.

  November 25, 2019

   · 

  6 min read